CA Stock MarketDetailed Quotes

TRIL Trillium Therapeutics Inc

Watchlist
  • 23.330
  • 0.0000.00%
15min DelayMarket Closed Apr 11 09:30 ET
2.45BMarket Cap-36058P/E (TTM)

Trillium Therapeutics Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2021
(Q2)Jun 30, 2021
(Q1)Mar 31, 2021
(FY)Dec 31, 2020
(Q4)Dec 31, 2020
(Q3)Sep 30, 2020
(Q2)Jun 30, 2020
(Q1)Mar 31, 2020
(FY)Dec 31, 2019
(Q4)Dec 31, 2019
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-232.57%-13.99M
-81.65%-11.48M
-134.22%-17.08M
8.15%-22.73M
-14.06%-4.92M
21.88%-4.21M
7.03%-6.32M
11.72%-7.29M
18.75%-24.75M
34.57%-4.31M
Net income from continuing operations
-54.44%-19.32M
20.76%-18.4M
33.35%-10.86M
-55.84%-59.35M
53.24%-7.32M
-31.06%-12.51M
-378.82%-23.22M
-102.99%-16.3M
-15.87%-38.08M
-137.21%-15.66M
Operating gains losses
106.82%6K
135.23%93K
-94.27%11K
-105.30%-325K
-101.46%-165K
88.70%-88K
93.10%-264K
136.64%192K
353.53%6.13M
895.46%11.26M
Depreciation and amortization
-67.35%48K
-64.43%53K
-72.11%41K
-2.96%591K
111.55%148K
-77.14%147K
-76.57%149K
-75.94%147K
-74.98%609K
-310.90%-1.28M
Remuneration paid in stock
-10.94%6.39M
-82.54%2.93M
-73.06%3.02M
692.76%36.45M
-61.16%1.3M
1,838.92%7.17M
5,374.84%16.75M
1,852.00%11.22M
137.25%4.6M
407.01%3.35M
Change In working capital
-204.40%-1.12M
1,380.00%3.85M
-263.43%-9.29M
-105.22%-104K
26.69%1.13M
-7.45%1.07M
-70.25%260K
-176.43%-2.56M
250.49%1.99M
25.43%888K
-Change in receivables
26.87%-98K
-6.22%-478K
113.22%16K
-221.33%-620K
-42.57%85K
-250.56%-134K
-240.91%-450K
-129.80%-121K
252.54%511K
605.55%148K
-Change in prepaid assets
-393.95%-5.55M
435.15%4.13M
-39.24%-3.04M
-1,364.05%-6.12M
-2,380.89%-3.58M
-617.97%-1.12M
663.37%771K
-24,366.67%-2.18M
822.39%484K
18.32%157K
-Change in payables and accrued expense
96.54%4.54M
351.22%206K
-2,924.04%-6.29M
549.75%6.62M
527.42%4.6M
220.67%2.31M
-109.11%-82K
84.42%-208K
208.40%1.02M
23.88%733K
-Change in other current assets
14.55%63K
17.31%61K
13.46%59K
46.62%217K
--58K
--55K
--52K
--52K
--148K
----
-Change in other current liabilities
-75.61%-72K
-116.13%-67K
61.46%-37K
-19.30%-204K
87.92%-36K
-132.28%-41K
-720.00%-31K
-1,820.00%-96K
-1,000.00%-171K
-2,426.65%-298K
Cash from discontinued investing activities
Operating cash flow
-232.57%-13.99M
-81.65%-11.48M
-134.22%-17.08M
8.15%-22.73M
-14.06%-4.92M
21.88%-4.21M
7.03%-6.32M
11.72%-7.29M
18.75%-24.75M
34.57%-4.31M
Investing cash flow
Cash flow from continuing investing activities
-2,279.64%-62.73M
-46.72%-67.39M
498.68%15.76M
-467.13%-35.48M
74.95%11.52M
-57.48%2.88M
-260.57%-45.93M
-143.70%-3.95M
-59.12%9.67M
-47.24%6.59M
Net PPE purchase and sale
--7K
---273K
---54K
--0
--0
--0
--0
--0
-414.29%-324K
-453.80%-96K
Net investment purchase and sale
-2,279.88%-62.74M
-46.13%-67.12M
500.05%15.82M
-455.22%-35.48M
72.43%11.52M
-57.50%2.88M
-262.90%-45.93M
-143.02%-3.95M
-57.87%9.99M
-46.54%6.68M
Cash from discontinued investing activities
Investing cash flow
-2,279.64%-62.73M
-46.72%-67.39M
498.68%15.76M
-467.13%-35.48M
74.95%11.52M
-57.48%2.88M
-260.57%-45.93M
-143.70%-3.95M
-59.12%9.67M
-47.24%6.59M
Financing cash flow
Cash flow from continuing financing activities
-99.93%112K
-51.17%895K
-98.64%1.63M
2,006.50%290.91M
1,568.57%3.5M
152,111.93%165.69M
564.05%1.83M
749.95%119.88M
15,616.85%13.81M
1,035.95%210K
Net issuance payments of debt
----
----
----
--0
----
----
----
----
17.98%-73K
1,035.95%210K
Net preferred stock issuance
--0
--0
--0
4,360.77%275.05M
--0
--165.31M
--0
--109.74M
--6.17M
----
Proceeds from stock option exercised by employees
-70.68%112K
-51.17%895K
-83.91%1.63M
105.47%15.86M
49.42%3.5M
--382K
571.21%1.83M
75.96%10.14M
--7.72M
--2.35M
Cash from discontinued financing activities
Financing cash flow
-99.93%112K
-51.17%895K
-98.64%1.63M
2,006.50%290.91M
1,568.57%3.5M
152,111.93%165.69M
564.05%1.83M
749.95%119.88M
15,616.85%13.81M
1,035.95%210K
Net cash flow
Beginning cash position
133.07%169.84M
101.51%247.91M
1,597.75%247.6M
-4.79%14.58M
1,820.51%237.26M
564.50%72.87M
309.97%123.02M
-4.79%14.58M
-31.95%15.32M
31.90%12.35M
Current changes in cash
-146.61%-76.61M
-54.66%-77.97M
-99.71%316K
18,335.97%232.69M
306.55%10.11M
12,781.27%164.37M
-152.95%-50.42M
629.46%108.63M
81.52%-1.28M
-57.66%2.49M
Effect of exchange rate changes
-123.08%-6K
-135.23%-93K
94.33%-11K
-40.04%325K
189.11%229K
-76.79%26K
-70.34%264K
4.43%-194K
289.51%542K
46.49%-257K
End cash Position
-60.71%93.23M
133.07%169.84M
101.51%247.91M
1,597.75%247.6M
1,597.75%247.6M
1,820.51%237.26M
564.50%72.87M
309.97%123.02M
-4.79%14.58M
-4.79%14.58M
Free cash from
-232.41%-13.98M
-85.97%-11.75M
-134.96%-17.13M
9.34%-22.73M
-11.58%-4.92M
21.91%-4.21M
8.14%-6.32M
13.23%-7.29M
17.85%-25.08M
33.29%-4.41M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2021(Q2)Jun 30, 2021(Q1)Mar 31, 2021(FY)Dec 31, 2020(Q4)Dec 31, 2020(Q3)Sep 30, 2020(Q2)Jun 30, 2020(Q1)Mar 31, 2020(FY)Dec 31, 2019(Q4)Dec 31, 2019
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -232.57%-13.99M-81.65%-11.48M-134.22%-17.08M8.15%-22.73M-14.06%-4.92M21.88%-4.21M7.03%-6.32M11.72%-7.29M18.75%-24.75M34.57%-4.31M
Net income from continuing operations -54.44%-19.32M20.76%-18.4M33.35%-10.86M-55.84%-59.35M53.24%-7.32M-31.06%-12.51M-378.82%-23.22M-102.99%-16.3M-15.87%-38.08M-137.21%-15.66M
Operating gains losses 106.82%6K135.23%93K-94.27%11K-105.30%-325K-101.46%-165K88.70%-88K93.10%-264K136.64%192K353.53%6.13M895.46%11.26M
Depreciation and amortization -67.35%48K-64.43%53K-72.11%41K-2.96%591K111.55%148K-77.14%147K-76.57%149K-75.94%147K-74.98%609K-310.90%-1.28M
Remuneration paid in stock -10.94%6.39M-82.54%2.93M-73.06%3.02M692.76%36.45M-61.16%1.3M1,838.92%7.17M5,374.84%16.75M1,852.00%11.22M137.25%4.6M407.01%3.35M
Change In working capital -204.40%-1.12M1,380.00%3.85M-263.43%-9.29M-105.22%-104K26.69%1.13M-7.45%1.07M-70.25%260K-176.43%-2.56M250.49%1.99M25.43%888K
-Change in receivables 26.87%-98K-6.22%-478K113.22%16K-221.33%-620K-42.57%85K-250.56%-134K-240.91%-450K-129.80%-121K252.54%511K605.55%148K
-Change in prepaid assets -393.95%-5.55M435.15%4.13M-39.24%-3.04M-1,364.05%-6.12M-2,380.89%-3.58M-617.97%-1.12M663.37%771K-24,366.67%-2.18M822.39%484K18.32%157K
-Change in payables and accrued expense 96.54%4.54M351.22%206K-2,924.04%-6.29M549.75%6.62M527.42%4.6M220.67%2.31M-109.11%-82K84.42%-208K208.40%1.02M23.88%733K
-Change in other current assets 14.55%63K17.31%61K13.46%59K46.62%217K--58K--55K--52K--52K--148K----
-Change in other current liabilities -75.61%-72K-116.13%-67K61.46%-37K-19.30%-204K87.92%-36K-132.28%-41K-720.00%-31K-1,820.00%-96K-1,000.00%-171K-2,426.65%-298K
Cash from discontinued investing activities
Operating cash flow -232.57%-13.99M-81.65%-11.48M-134.22%-17.08M8.15%-22.73M-14.06%-4.92M21.88%-4.21M7.03%-6.32M11.72%-7.29M18.75%-24.75M34.57%-4.31M
Investing cash flow
Cash flow from continuing investing activities -2,279.64%-62.73M-46.72%-67.39M498.68%15.76M-467.13%-35.48M74.95%11.52M-57.48%2.88M-260.57%-45.93M-143.70%-3.95M-59.12%9.67M-47.24%6.59M
Net PPE purchase and sale --7K---273K---54K--0--0--0--0--0-414.29%-324K-453.80%-96K
Net investment purchase and sale -2,279.88%-62.74M-46.13%-67.12M500.05%15.82M-455.22%-35.48M72.43%11.52M-57.50%2.88M-262.90%-45.93M-143.02%-3.95M-57.87%9.99M-46.54%6.68M
Cash from discontinued investing activities
Investing cash flow -2,279.64%-62.73M-46.72%-67.39M498.68%15.76M-467.13%-35.48M74.95%11.52M-57.48%2.88M-260.57%-45.93M-143.70%-3.95M-59.12%9.67M-47.24%6.59M
Financing cash flow
Cash flow from continuing financing activities -99.93%112K-51.17%895K-98.64%1.63M2,006.50%290.91M1,568.57%3.5M152,111.93%165.69M564.05%1.83M749.95%119.88M15,616.85%13.81M1,035.95%210K
Net issuance payments of debt --------------0----------------17.98%-73K1,035.95%210K
Net preferred stock issuance --0--0--04,360.77%275.05M--0--165.31M--0--109.74M--6.17M----
Proceeds from stock option exercised by employees -70.68%112K-51.17%895K-83.91%1.63M105.47%15.86M49.42%3.5M--382K571.21%1.83M75.96%10.14M--7.72M--2.35M
Cash from discontinued financing activities
Financing cash flow -99.93%112K-51.17%895K-98.64%1.63M2,006.50%290.91M1,568.57%3.5M152,111.93%165.69M564.05%1.83M749.95%119.88M15,616.85%13.81M1,035.95%210K
Net cash flow
Beginning cash position 133.07%169.84M101.51%247.91M1,597.75%247.6M-4.79%14.58M1,820.51%237.26M564.50%72.87M309.97%123.02M-4.79%14.58M-31.95%15.32M31.90%12.35M
Current changes in cash -146.61%-76.61M-54.66%-77.97M-99.71%316K18,335.97%232.69M306.55%10.11M12,781.27%164.37M-152.95%-50.42M629.46%108.63M81.52%-1.28M-57.66%2.49M
Effect of exchange rate changes -123.08%-6K-135.23%-93K94.33%-11K-40.04%325K189.11%229K-76.79%26K-70.34%264K4.43%-194K289.51%542K46.49%-257K
End cash Position -60.71%93.23M133.07%169.84M101.51%247.91M1,597.75%247.6M1,597.75%247.6M1,820.51%237.26M564.50%72.87M309.97%123.02M-4.79%14.58M-4.79%14.58M
Free cash from -232.41%-13.98M-85.97%-11.75M-134.96%-17.13M9.34%-22.73M-11.58%-4.92M21.91%-4.21M8.14%-6.32M13.23%-7.29M17.85%-25.08M33.29%-4.41M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data